(Q39502702)

English

Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.

scientific article published on 30 August 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21780100%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21780100%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

prostate carcinoma

1 reference

based on heuristic

inferred from title

Horng-Heng Juang

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21780100%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Ke-Hung Tsui

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21780100%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Li-Chuan Chung

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21780100%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Tsui-Hsia Feng

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21780100%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Phei-Lang Chang

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21780100%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

language of work or name

0 references

publication date

30 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21780100%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21780100%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

130

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21780100%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21780100%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

2812-2823

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21780100%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

PDEF, a novel prostate epithelium-specific ets transcription factor, interacts with the androgen receptor and activates prostate-specific antigen gene expression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Silibinin down-regulates prostate epithelium-derived Ets transcription factor in LNCaP prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Tectorigenin and other phytochemicals extracted from leopard lily Belamcanda chinensis affect new and established targets for therapies in prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Cardiac glycosides decrease prostate specific antigen expression by down-regulation of prostate derived Ets factor.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Curcumin blocks the activation of androgen and interlukin-6 on prostate-specific antigen expression in human prostatic carcinoma cells.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Proteomic analysis of a PDEF Ets transcription factor-interacting protein complex

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Identification of genes associated with stromal hyperplasia and glandular atrophy of the prostate by mRNA differential display

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Triiodothyronine modulates cell proliferation of human prostatic carcinoma cells by downregulation of the B-cell translocation gene 2.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Perspectives for cancer prevention with natural compounds

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Inhibition of fatty acid synthase by luteolin post-transcriptionally down-regulates c-Met expression independent of proteosomal/lysosomal degradation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Effect of flavonoids on cell cycle progression in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Zinc blocks gene expression of mitochondrial aconitase in human prostatic carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Down-regulation of the prostate specific antigen promoter by p53 in human prostate cancer cells.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Identifying the combination of the transcriptional regulatory sequences on prostate specific antigen and human glandular kallikrein genes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 2: Androgen-receptor cofactors and bypass pathways

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Phytoestrogens from Belamcanda chinensis regulate the expression of steroid receptors and related cofactors in LNCaP prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

The gene PC3(TIS21/BTG2), prototype member of the PC3/BTG/TOB family: regulator in control of cell growth, differentiation, and DNA repair?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Antiproliferative B cell translocation gene 2 protein is down-regulated post-transcriptionally as an early event in prostate carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Novel pathways associated with bypassing cellular senescence in human prostate epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Antiproliferative proteins of the BTG/Tob family are degraded by the ubiquitin-proteasome system

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoids

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Luteolin induces apoptosis in oral squamous cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Induction of cell cycle arrest and apoptosis in HT-29 human colon cancer cells by the dietary compound luteolin

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: regulation of MMP 9 by PDEF.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Transcriptional regulation of p21/CIP1 cell cycle inhibitor by PDEF controls cell proliferation and mammary tumor progression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Quantitative multi-gene expression profiling of primary prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Expression characteristics of prostate-derived Ets factor support a role in breast and prostate cancer progression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Prostate-derived Ets transcription factor (PDEF) downregulates survivin expression and inhibits breast cancer cell growth in vitro and xenograft tumor formation in vivo

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Prostate-derived Ets transcription factor as a favorable prognostic marker in ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Prostate-derived ETS factor is a mediator of metastatic potential through the inhibition of migration and invasion in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

MicroRNA-mediated inhibition of prostate-derived Ets factor messenger RNA translation affects prostate-derived Ets factor regulatory networks in human breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Sam-pointed domain containing Ets transcription factor in luminal breast cancer pathogenesis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Maspin augments proteasome inhibitor-induced apoptosis in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Adeno-associated virus 2-mediated intratumoral prostate cancer gene therapy: long-term maspin expression efficiently suppresses tumor growth

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Maspin reduces prostate cancer metastasis to bone

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Proteomics analysis of the interactome of N-myc downstream regulated gene 1 and its interactions with the androgen response program in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26284

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39502702&oldid=1505534255"